Total Funding
27
43
Total FundingPrivate Equity raised
Growth Score 27 in past quarter
-8 pts
Heat Score 43 in past quarter
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
124943
Abzena is a biotechnology company that offers biologic and ADC products from concept to clinic.
Acquired by 

Welsh Carson Anderson & Stowe
- Michelle Neaves: Head of Finance
- Sven Lee: Chief Business Officer
About the Company
Abzena is a biologics research partner. They provide biologic and ADC products from concept to clinic. They develop biologics and bioconjugates, and provides the solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry.
